Advertisement

Adverse Drug Reactions in Rheumatology

  • Eleftherios Pelechas
  • Evripidis Kaltsonoudis
  • Paraskevi V. Voulgari
  • Alexandros A. Drosos
Chapter

Abstract

There is a high probability of developing adverse drug reactions (ADRs) in rheumatology. Corticosteroids (CS) as well as different classes of disease-modifying anti-rheumatic drugs (DMARDs) are the commonest suspected drugs for variable ADRs. Even if these drugs are widely known for their efficacy on rheumatic diseases, it is necessary to know what to expect and how to treat a possible ADR. At this chapter we present some common but also some more seldom ADRs.

References and Further Reading

  1. Bonomo L, Ghoneim S, Levitt J. A case of granuloma Annulare associated with Secukinumab use. Case Rep Dermatol Med. 2017;2017:5918708.PubMedPubMedCentralGoogle Scholar
  2. Costanzo L, Ayala F, Megna M, et al. The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature. J Dermatol Case Rep. 2013;7(1):1–4.CrossRefGoogle Scholar
  3. Devos SA, Van Den Bossche N, De Vos M, Naeyaert JM. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology. 2003;206(4):388–90.CrossRefGoogle Scholar
  4. Exarchou SA, Voulgari PV, Markatseli TE, Zioga A, Drosos AA. Immune-mediated skin lesions in patients treated with anti-tumour necrosis factor alpha inhibitors. Scand J Rheumatol. 2009;38(5):328–31.CrossRefGoogle Scholar
  5. Kaltsonoudis E, Zikou AK, Voulgari PV, Konitsiotis S, Argyropoulou MI, Drosos AA. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther. 2014;16(3):R125.CrossRefGoogle Scholar
  6. Markatseli TE, Kaltsonoudis ES, Voulgari PV, Zioga A, Drosos AA. Induction of psoriatic skin lesions in a patient with rheumatoid arthritis treated with rituximab. Clin Exp Rheumatol. 2009;27(6):996–8.PubMedGoogle Scholar
  7. Marra F, Lo E, Kalashnikov V, et al. Risk of herpes zoster in individuals on biologics, disease-modifying antirheumatic drugs, and/or corticosteroids for autoimmune diseases: a systematic review and meta-analysis. Open Forum Infect Dis. 2016;3(4):ofw205.CrossRefGoogle Scholar
  8. Moustou AE, Matekovits A, Dessinioti C, Antoniou C, Sfkikakis PP, Stratigos AJ. Cutaneous side effects of anti-tumor necrosis factor biologic therapy: a clinical review. J Am Acad Dermatol. 2009;61(3):486–504.CrossRefGoogle Scholar
  9. Nikas SN, Kittas G, Karamaounas N, Drosos AA. Meloxicam-induced erythema multiforme. Am J Med. 1999;107(5):532–4.CrossRefGoogle Scholar
  10. Nikas SN, Voulgari PV, Drosos AA. Urticaria and angiedema-like skin reactions in a patient treated with adalimumab. Clin Rheumatol. 2007;26(5):787–8.CrossRefGoogle Scholar
  11. Pelechas E, Drosos AA. Hydroxychloroquine-induced dark butterfly rash in a rheumatoid arthritis patient. Rheumatology (Oxford). 2017; https://doi.org/10.1093/rheumatology/kex388.CrossRefGoogle Scholar
  12. Ratnarathorn M, Raychaudhuri SP, Naguwa S. Disseminated granuloma annulare: a cutaneous adverse effect of anti-tnf agents. Indian J Dermatol. 2011;56(6):752–4.CrossRefGoogle Scholar
  13. Sand FL, Thomsen SF. Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients. Dermatol Ther. 2015;28(3):158–65.CrossRefGoogle Scholar
  14. Sfikakis PP, Iliopoulos A, Elezoglou A, Kittas C, Stratigos A. Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction. Arthritis Rheum. 2005;52(8):2513–8.CrossRefGoogle Scholar
  15. Viguier M, Richette P, Bachelez H, Wendling D, Aubin F. Paradoxical cutaneous manifestations during anti-TNF-alpha therapy. Ann Dermatol Venereol. 2010;137(1):64–71. quiz 63, 78-9.CrossRefGoogle Scholar
  16. Voulgari PV, Drosos AA. Gingival hyperplasia associated with cyclosporin A. J Rheumatol. 2002;29(11):2466.PubMedGoogle Scholar
  17. Voulgari PV, Markatseli TE, Exarchou SA, Zioga A, Drosos AA. Granuloma annulare induced by anti-tumour necrosis factor therapy. Ann Rheum Dis. 2008;67(4):567–70.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Eleftherios Pelechas
    • 1
  • Evripidis Kaltsonoudis
    • 1
  • Paraskevi V. Voulgari
    • 1
  • Alexandros A. Drosos
    • 1
  1. 1.Rheumatology Clinic - Department of Internal MedicineUniversity of IoanninaIoanninaGreece

Personalised recommendations